Baseline Characteristics and Treatment Patterns of New Users to Multiple Inhaler Triple Therapy

被引：0
|
作者：
Stanford, R. H. [1 ]
Hull, M. S. [2 ]
Hulbert, E. [2 ]
Buikema, A. R. [2 ]
Reinsch, T. K. [1 ]
Bogart, M. [1 ]
机构：
[1] GlaxoSmithKline, Res Triangle Pk, NC USA
[2] Optum, Eden Prairie, MN USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 197卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4999
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Comparison of treatment persistence, adherence, and risk of exacerbation in patients with COPD treated with single-inhaler versus multiple-inhaler triple therapy: A prospective observational study in China
    Lin, Ling
    Liu, Cong
    Cheng, Wei
    Song, Qing
    Zeng, Yuqin
    Li, Xin
    Deng, Dingding
    Liu, Dan
    Chen, Yan
    Cai, Shan
    Chen, Ping
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [42] BUDGET IMPACT ANALYSIS OF A SINGLE-INHALER TRIPLE THERAPY (TRELEGYA') VERSUS DUAL COMBINATION AND MULTIPLE-INHALER TRIPLE THERAPY FOR THE TREATMENT OF PATIENTS WITH COPD MODERATE TO VERY-SEVERE FROM PUBLIC HEALTH SYSTEM PERSPECTIVE IN CHILE
    Balmaceda, C.
    Abbott, T.
    Espinoza, M. A.
    VALUE IN HEALTH, 2020, 23 : S354 - S354
  • [43] CHARACTERISTICS AND TREATMENT PATTERNS OF MEDICARE BENEFICIARIES WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Hlavacek, P.
    Silverstein, A.
    Petrilla, A.
    Leinwand, B., I
    Johnson, W.
    Schroeder, A.
    VALUE IN HEALTH, 2022, 25 (07) : S486 - S487
  • [44] Characteristics and Outcomes of COPD Patients with Blood Eosinophils ≥ 150 Cells/μL Who Continue to Exacerbate Whilst Treated with Multiple Inhaler Triple Therapy
    Mullerova, H.
    Galkin, D.
    Albers, F. C.
    Landis, S. H.
    Meeraus, W. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [45] DISCONTINUATION AND RE-INITIATION OF MULTIPLE INHALER TRIPLE THERAPY IN ADULT PATIENTS WITH ASTHMA: A COHORT STUDY
    Meeraus, Wilhelmine
    Liu, Yunhao
    Numbere, Beade
    Zhang, Shiyuan
    Czira, Alexandrosz
    Gardiner, Frances
    Slade, David
    CHEST, 2021, 160 (04) : 1958A - 1959A
  • [46] INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice
    Halpin, David M. G.
    Worsley, Sally
    Ismaila, Afisi S.
    Beeh, Kai-Michael
    Midwinter, Dawn
    Kocks, Janwillem W. H.
    Irving, Elaine
    Marin, Jose M.
    Martin, Neil
    Tabberer, Maggie
    Snowise, Neil G.
    Compton, Chris
    ERJ OPEN RESEARCH, 2021, 7 (02)
  • [47] COPD Exacerbations in Patients Switched from Multiple-Inhaler Triple Therapy to FF/UMEC/VI
    Beeh, K. M.
    Bogart, M.
    Ismaila, A. S.
    Bangalore, M.
    Bengtson, L. G. S.
    Brunner, S.
    INTERNIST, 2022, 63 (SUPPL 3): : 354 - 355
  • [48] COPD EXACERBATIONS IN PATIENTS SWITCHED FROM MULTIPLE-INHALER TRIPLE THERAPY TO FF/UMEC/VI
    Bogart, Michael
    Ismaila, Afisi
    Bangalore, Mohan
    Bunner, Scott
    Bengtson, Lindsay
    CHEST, 2021, 160 (04) : 1830A - 1830A
  • [49] Prediction of response to neoadjuvant systemic therapy in triple negative breast cancer using baseline tumor MRI characteristics and imaging patterns of response
    Guirguis, Mary S.
    Adrada, Beatriz E.
    Candelaria, Rosalind P.
    Sun, Jia
    Whitman, Gary J.
    Yang, Wei T.
    Boge, Medine
    Mohamed, Rania M.
    Elshafeey, Nabil A.
    Lane, Deanna L.
    Le-Petross, Huong
    Leung, Jessica W. T.
    Santiago, Lumarie
    Scoggins, Marion E.
    Spak, David A.
    Patel, Miral
    Perez, Frances
    Wei, Peng
    Tripathy, Debu
    White, Jason
    Ravenberg, Elizabeth
    Huo, Lei
    Litton, Jennifer
    Arun, Banu
    Valero, Vincente
    Thompson, Alastair
    Moulder, Stacy
    Yam, Clinton
    Rauch, Gaiane M.
    CANCER RESEARCH, 2022, 82 (04)
  • [50] Characteristics of opiate users presenting for a new treatment episode: Baseline data from the national drug treatment outcome study in Ireland (ROSIE)
    Cox, Gemma
    Comiskey, Catherine
    DRUGS-EDUCATION PREVENTION AND POLICY, 2007, 14 (03) : 217 - 230
12345